173 related articles for article (PubMed ID: 22644618)
21. Urine 6-sulfatoxymelatonin levels are inversely associated with arterial stiffness in post-menopausal women.
Lee JY; Lee DC
Maturitas; 2014 Jun; 78(2):117-22. PubMed ID: 24780409
[TBL] [Abstract][Full Text] [Related]
22. Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.
Chen W; Cao H; Lu QY; Wang N; Zhao SZ; Xu X; Zheng Z
Int J Clin Exp Pathol; 2014; 7(7):4317-22. PubMed ID: 25120815
[TBL] [Abstract][Full Text] [Related]
23. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
[TBL] [Abstract][Full Text] [Related]
24. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
Bartsch C; Bartsch H; Karenovics A; Franz H; Peiker G; Mecke D
J Pineal Res; 1997 Sep; 23(2):53-8. PubMed ID: 9392442
[TBL] [Abstract][Full Text] [Related]
25. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
Schernhammer ES; Kroenke CH; Dowsett M; Folkerd E; Hankinson SE
J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548
[TBL] [Abstract][Full Text] [Related]
26. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin.
Tzischinsky O; Shlitner A; Lavie P
J Biol Rhythms; 1993; 8(3):199-209. PubMed ID: 8280909
[TBL] [Abstract][Full Text] [Related]
27. Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer.
Barba M; Cavalleri A; Schünemann HJ; Krogh V; Evangelista A; Secreto G; Micheli A; Zhou Q; Fuhrman B; Teter B; Berrino F; Muti P
Int J Biol Markers; 2006; 21(4):242-5. PubMed ID: 17177163
[TBL] [Abstract][Full Text] [Related]
28. Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
Erren TC; Reiter RJ
Int J Cancer; 2013 Oct; 133(8):2010-1. PubMed ID: 23588800
[No Abstract] [Full Text] [Related]
29. Author's reply to: Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
Wu AH; Yu MC
Int J Cancer; 2013 Oct; 133(8):2012. PubMed ID: 23588716
[No Abstract] [Full Text] [Related]
30. Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis.
Xu J; Huang L; Sun GP
Sci Rep; 2017 Jul; 7(1):5353. PubMed ID: 28706222
[TBL] [Abstract][Full Text] [Related]
31. Sleep variability, 6-sulfatoxymelatonin, and diabetic retinopathy.
Sirisreetreerux S; Sujirakul T; Nimitphong H; Pinyopodjanard S; Saetung S; Chailurkit LO; Chirakalwasan N; Gerber BS; Reutrakul S
Sleep Breath; 2021 Jun; 25(2):1069-1074. PubMed ID: 32951070
[TBL] [Abstract][Full Text] [Related]
32. The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers.
Ramin CA; Massa J; Wegrzyn LR; Brown SB; Pierre-Paul J; Devore EE; Hankinson SE; Schernhammer ES
BMC Public Health; 2015 May; 15():467. PubMed ID: 25943349
[TBL] [Abstract][Full Text] [Related]
33. Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study.
Talaei M; Lee BL; Ong CN; van Dam RM; Yuan JM; Koh WP; Pan A
Br J Nutr; 2016 May; 115(9):1607-15. PubMed ID: 26949260
[TBL] [Abstract][Full Text] [Related]
34. Lower nocturnal urinary 6-sulfatoxymelatonin is associated with more severe insulin resistance in patients with prediabetes.
Reutrakul S; Sumritsopak R; Saetung S; Chanprasertyothin S; Chailurkit LO; Anothaisintawee T
Neurobiol Sleep Circadian Rhythms; 2018 Jan; 4():10-16. PubMed ID: 31236502
[TBL] [Abstract][Full Text] [Related]
35. 6-sulphatoxymelatonin production in breast cancer patients.
Skene DJ; Bojkowski CJ; Currie JE; Wright J; Boulter PS; Arendt J
J Pineal Res; 1990; 8(3):269-76. PubMed ID: 2380908
[TBL] [Abstract][Full Text] [Related]
36. Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer's disease.
Luboshitzky R; Shen-Orr Z; Tzischichinsky O; Maldonado M; Herer P; Lavie P
Chronobiol Int; 2001 May; 18(3):513-24. PubMed ID: 11475420
[TBL] [Abstract][Full Text] [Related]
37. Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosis.
Montagnese S; Middleton B; Corrias M; Mani AR; Skene DJ; Morgan MY
Chronobiol Int; 2015 Mar; 32(2):187-94. PubMed ID: 25264562
[TBL] [Abstract][Full Text] [Related]
38. Effects of physical activity on melatonin levels in previously sedentary men and women.
Thrift AP; Xiao L; Patel SR; Tworoger SS; McTiernan A; Duggan C
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1696-9. PubMed ID: 24859868
[TBL] [Abstract][Full Text] [Related]
39. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W
Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724
[TBL] [Abstract][Full Text] [Related]
40. Long-term alteration of daily melatonin, 6-sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: a preliminary report.
Pina G; Brun J; Tissot S; Claustrat B
Chronobiol Int; 2010 Jan; 27(2):378-92. PubMed ID: 20370476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
